Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.67 |
| ▸ | CA2 | P00918 | 15/20 | 0.67 |
| ▸ | CA9 | Q16790 | 13/20 | 0.67 |
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA6 | P23280 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9097777 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL771782 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL456239 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5718521 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL1459889 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10725960 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5710133 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL185576 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336074 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL44522 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111671971-B | Polypeptide single-layer film with 6% primary amino group exposure and preparation method and application thereof | 齐鲁工业大学 | 2022-01-25 | — | — | CN | claimed |
| EP-3423031-B1 | AEROSOL ANTIDANDRUFF COMPOSITION | PROCTER & GAMBLE (US) | 2021-09-08 | — | — | EP | claimed |
| WO-2021127768-A1 | ANTI-PERSPIRANT COMPOSITION, COSMETIC USE AND METHOD FOR APPLYING SAME | HART'S ALIMENTOS NATURAIS LTDA (BR) | 2021-07-01 | — | — | WO | claimed |
| US-9968535-B2 | Personal care compositions comprising undecyl sulfates | THE PROCTER & GAMBLE COMPANY (US) | 2018-05-15 | — | — | US | claimed |
| EP-3285722-A1 | A LOW VISCOSITY HAIR CARE COMPOSITION | The Procter and Gamble Company (US) | 2018-02-28 | — | — | EP | claimed |
| WO-2016172405-A1 | A LOW VISCOSITY HAIR CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2016-10-27 | — | — | WO | claimed |
| US-20160310370-A1 | LOW VISCOSITY HAIR CARE COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2016-10-27 | — | — | US | claimed |
| EP-2203150-B1 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | PROCTER & GAMBLE (US) | 2016-06-01 | — | — | EP | claimed |
| US-9308398-B2 | Multiple product system for hair comprising a conditioner with a specific yield point | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-12 | — | — | US | claimed |
| WO-2015191686-A1 | METHODS OF ADMINISTERING METHYLNALTREXONE | SALIX PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| CN-103910880-A | Preparation method for helical structure polyaniline, helical structure polyaniline and application | CHONGQING JINGUTE CHEMICAL NEW MATERIAL TECHNOLOGY CO LTD | 2014-07-09 | — | — | CN | claimed |
| EP-2437720-A2 | MULTIPLE PRODUCT SYSTEM FOR HAIR | The Procter & Gamble Company (US) | 2012-04-11 | — | — | EP | claimed |
| US-20110048449-A1 | Multiple Product System For Hair | THE PROCTER & GAMBLE COMPANY | 2011-03-03 | — | — | US | claimed |
| WO-2010141683-A2 | MULTIPLE PRODUCT SYSTEM FOR HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2010-12-09 | — | — | WO | claimed |
| EP-2203150-A2 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | The Procter & Gamble Company (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | THE PROCTER & GAMBLE COMPANY | 2009-06-18 | — | — | US | claimed |
| WO-2009053931-A2 | PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL SULFATES | THE PROCTER & GAMBLE COMPANY (US) | 2009-04-30 | — | — | WO | claimed |
| EP-0461835-B1 | Method for purifying organic solution containing lactams | UBE INDUSTRIES (JP) | 1997-09-24 | — | — | EP | claimed |
| US-5440032-A | Neutralization of reaction solution from Beckman rearrangement then solvent extraction of dodecanelactam layer and treatment with anionic exchange resin, water extraction of caprolactam layer | UBE INDUSTRIES, LTD. (JP) | 1995-08-08 | — | — | US | claimed |
| EP-0461835-A2 | Method for purifying organic solution containing lactams | UBE INDUSTRIES, LTD. (JP) | 1991-12-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090155383-A1 | Personal Care Compositions Comprising Undecyl Sulfates | USP25, UTS2R, USP30 | CA1 4862/4885CA2 4769/4885CA9 2967/4885 |
| US-20160310370-A1 | LOW VISCOSITY HAIR CARE COMPOSITION | POLR1C, PSAP, PTCD3 | CA1 2942/4885CA2 2864/4885CA9 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.